Bellerophon Therapeutics Inc (BLPH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Bellerophon Therapeutics Inc (BLPH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7939
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product candidate, INOpulse, a combination drug-device therapy intended for the treatment of pulmonary hypertension associated with interstitial lung disease, pulmonary hypertension associated with sarcoidosis and pulmonary hypertension associated with chronic obstructive pulmonary disease. It develops INOpulse platform is based on its proprietary pulsatile nitric oxide delivery device. Bellerophon Therapeutics is headquartered in Warren, New Jersey, the US.

Bellerophon Therapeutics Inc (BLPH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bellerophon Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Bellerophon Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bellerophon Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Bellerophon Therapeutics Raises Funds through Venture Financing 10
Bellerophon Therapeutics Secures USD80 Million in Venture Funding 11
Partnerships 12
Bellerophon Therapeutics Extends Licensing Agreement With INO Therapeutics 12
Bellerophon Amends Licensing Agreement With Ikaria 13
Equity Offering 14
Bellerophon Therapeutics Plans to Raise up to USD100 Million in Public offering of Securities 14
Bellerophon Therapeutics Plans to Raise Funds through Public Offering 15
Bellerophon Therapeutics Raises USD23.4 Million in Private Placement of Units 16
Bellerophon Therapeutics Raises USD12 Million in Public Offering of Shares 18
Bellerophon Therapeutics to Raise USD5.7 Million in Public offering of Shares 19
Bellerophon Therapeutics Raises USD60 Million in IPO 20
Bellerophon Therapeutics Inc – Key Competitors 22
Bellerophon Therapeutics Inc – Key Employees 23
Bellerophon Therapeutics Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Financial Announcements 25
Aug 01, 2018: Bellerophon provides business update and reports second quarter 2018 financial results 25
May 10, 2018: Bellerophon Provides Business Update and Reports First Quarter 2018 Financial Results 27
Mar 15, 2018: Bellerophon Reports Fourth Quarter and Full-Year 2017 Financial Results 29
Nov 07, 2017: Bellerophon Provides Business Update and Reports Third Quarter 2017 Financial Results 31
Aug 07, 2017: Bellerophon Reports Second Quarter 2017 Financial Results and Provides Business Update 33
May 15, 2017: Bellerophon Reports First Quarter 2017 Financial Results and Provides Business Update 35
Mar 13, 2017: Bellerophon Reports Fourth Quarter 2016 Financial Results and Provides Business Update 37
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Bellerophon Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Bellerophon Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bellerophon Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bellerophon Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Bellerophon Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bellerophon Therapeutics Raises Funds through Venture Financing 10
Bellerophon Therapeutics Secures USD80 Million in Venture Funding 11
Bellerophon Therapeutics Extends Licensing Agreement With INO Therapeutics 12
Bellerophon Amends Licensing Agreement With Ikaria 13
Bellerophon Therapeutics Plans to Raise up to USD100 Million in Public offering of Securities 14
Bellerophon Therapeutics Plans to Raise Funds through Public Offering 15
Bellerophon Therapeutics Raises USD23.4 Million in Private Placement of Units 16
Bellerophon Therapeutics Raises USD12 Million in Public Offering of Shares 18
Bellerophon Therapeutics to Raise USD5.7 Million in Public offering of Shares 19
Bellerophon Therapeutics Raises USD60 Million in IPO 20
Bellerophon Therapeutics Inc, Key Competitors 22
Bellerophon Therapeutics Inc, Key Employees 23

List of Figures
Bellerophon Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bellerophon Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Bellerophon Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bellerophon Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Bellerophon Therapeutics Inc (BLPH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orbotech Ltd.:企業の戦略的SWOT分析
    Orbotech Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Clinical Innovations LLC:医療機器:M&Aディール及び事業提携情報
    Summary Clinical Innovations LLC (Clinical Innovations), a portfolio company of EQT AB, is a medical device company that researches and manufactures healthcare products to improve the lives of mothers and their babies. The company focuses on labor, delivery and neonatal intensive care. Its major pro …
  • Mobile Telesystems
    Mobile Telesystems - Strategy, SWOT and Corporate Finance Report Summary Mobile Telesystems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • AGL Energy Ltd (AGL):企業の財務・戦略的SWOT分析
    AGL Energy Ltd (AGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sihayo Gold Ltd:企業の戦略・SWOT・財務分析
    Sihayo Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Sihayo Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Trendlines Group Ltd (42T):製薬・医療:M&Aディール及び事業提携情報
    Summary The Trendlines Group Ltd (Trendlines) is a commercialization company that invents, discovers, invests, and incubates medical and agricultural technologies. The company offers business incubation, partner and channel development, market strategies, business plans, research and development and …
  • Wartsila Corporation (WRT1V):電力:M&Aディール及び事業提携情報
    Summary Wartsila Corporation (Wartsila) is a mechanical or industrial engineering company. It offers smart technologies and complete lifecycle solutions. Through sustainable innovation, total efficiency, and data analytics, the company harnesses the environmental and economic performance of the vess …
  • Canon Marketing Japan Inc (8060):企業の財務・戦略的SWOT分析
    Canon Marketing Japan Inc (8060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Carl Zeiss Meditec AG (AFX):医療機器:M&Aディール及び事業提携情報
    Summary Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, is an integrated medical technology company, which provides visualization solutions for minimally invasive surgical treatments. It operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. T …
  • Pharmaxis Ltd (PXS):企業の財務・戦略的SWOT分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company provides products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves …
  • Axpo Holding AG-エネルギー分野:企業M&A・提携分析
    Summary Axpo Holding AG (Axpo) is an electricity utility that produces, trades and sells electricity. It is wholly owned by the cantons of Northeastern Switzerland. The company covers the entire value chain from power generation and marketing of a wide range of products to power distribution. It gen …
  • PNM Resources, Inc.:企業の発電所・SWOT分析2018
    PNM Resources, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Yantai Dongcheng Pharmaceutical Group Co Ltd (002675):製薬・医療:M&Aディール及び事業提携情報
    Summary Yantai Dongcheng Pharmaceutical Group Co Ltd (Yantai Dongcheng Pharma), formerly Yantai Dongcheng Biochemicals Co Ltd, is a developer, manufacturer, and marketer of biochemical API, chemical synthetic drugs, and Chinese medicines. The company offers its products under categories including he …
  • Zensho Holdings Co., Ltd. :企業の戦略・SWOT・財務情報
    Zensho Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Zensho Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Avedro Inc:医療機器:M&Aディール及び事業提携情報
    Summary Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-lin …
  • iKang Healthcare Group Inc:企業の戦略・SWOT・財務情報
    iKang Healthcare Group Inc - Strategy, SWOT and Corporate Finance Report Summary iKang Healthcare Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Lampsa Hotel Company
    Lampsa Hotel Company - Strategy, SWOT and Corporate Finance Report Summary Lampsa Hotel Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nuo Therapeutics Inc (AURX):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. T …
  • Empire Genomics LLC-医療機器分野:企業M&A・提携分析
    Summary Empire Genomics LLC (Genomics) is a medical device company that offers molecular diagnostic solutions. The company offers ID labs products, fish probes, BAC clones, genotyping and circulating tumor cell products. Its services comprise array CGH, gene expression, clinical and custom services. …
  • Namibia Power Corporation (Proprietary) Ltd:企業の戦略的SWOT分析
    Namibia Power Corporation (Proprietary) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆